Pharmaceuticals, Biotechnology and Life Sciences
Conference call and webcast at 5:00 p.m. ET today, March 29, 2022MENLO PARK, Calif., March 29, 2022 (GLOBE NEWSWIRE) —…
-Total revenue of $9.3 million driven by continued SIVEXTRO prescription growth- -Net product sales increased 8% sequentially in Q4 2021…
NX-1607 is being evaluated in multiple immuno-oncology indications, including a range of solid tumor types The ILAP aims to accelerate…
Sanofi continues on path to industry leadership in Immunology with Dupixent® (dupilumab) as key driver Dupixent peak sales ambition raised…
VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) — Novelion Therapeutics Inc. (“Novelion” or the “Company”) by Alvarez & Marsal…
Bagsværd, Denmark, 28 March 2022 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a…
Regulated information March 28, 2022, 10:30 PM CETMarch 28, 2022, 4:30 PM ET Breda, the Netherlands / Ghent, Belgium — argenx SE…
AUSTIN, Texas, March 28, 2022 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company…
BOCA RATON, Fla., March 28, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”),…
Several anticipated catalysts in 2022 aim to advance Aileron’s vision to bring chemoprotection against multiple toxicities to all patients with…